IART Stock to Gain From New Study Findings on DuraSeal Dural Sealant

Integra LifeSciences Holding Corporation (IART) has announced the publication of a new economic study assessing the budget impact of switching treatment from fibrin glue to DuraSeal Polyethylene Glycol (“PEG”) hydrogel in five major European countries. The findings show an average cost savings of €419 to €1,279 per patient, with a consistent cost reduction averaging around 22% per procedure across Belgium, France, Germany and the United Kingdom, and 15% in Italy.The study, “PEG hydrogel sealant versus fibri ...